NEW YORK (GenomeWeb News) — Pharmacogenomics company AssureRx said today it has received a round of funding led by Cincinnati-area investors. The company did not disclose the amount of financing it received.
 
Investors in the round include Queen City Angels, Cincy Tech USA, the Health Foundation of Greater Cincinnati, Blue Chip Venture Company, Cincinnati Children’s Tomorrow Fund, and individual investors.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.

A small study finds differences between three genomic prostate cancer tests, Medscape reports.

In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.

A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.